Pfizer Inc. (PFE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pfizer Inc.

    NYSE: PFE · Real-Time Price · USD
    23.76
    0.16 (0.68%)
    At close: Sep 26, 2025, 3:59 PM
    23.77
    0.04%
    After-hours: Sep 26, 2025, 07:57 PM EDT

    Pfizer Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 63.63B 59.55B 100.33B 81.29B
    Cost of Revenue
    		 21.78B 29.21B 38.24B 34.41B
    Gross Profit
    		 41.85B 30.34B 62.09B 46.88B
    Operating Income
    		 16.48B 5.29B 37.55B 20.79B
    Interest Income
    		 545M 1.62B 251M 36M
    Pretax Income
    		 8.02B 1.06B 34.73B 24.31B
    Net Income
    		 8.02B 2.13B 31.36B 22.15B
    Selling & General & Admin
    		 14.63B 14.47B 13.12B 12.25B
    Research & Development
    		 10.74B 10.58B 11.43B 13.83B
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 25.36B 25.05B 24.54B 26.08B
    Interest Expense
    		 3.09B 2.21B 1.24B 1.29B
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 47.14B 54.26B 62.78B 60.49B
    Income Tax Expense
    		 -28M -1.11B 3.33B 1.85B
    Shares Outstanding (Basic)
    		 5.66B 5.64B 5.61B 5.6B
    Shares Outstanding (Diluted)
    		 5.7B 5.71B 5.73B 5.71B
    EPS (Basic)
    		 1.42 0.38 5.59 3.95
    EPS (Diluted)
    		 1.41 0.37 5.47 3.88
    EBITDA
    		 18.13B 9.56B 41.03B 30.79B
    EBIT
    		 11.11B 3.27B 35.97B 25.6B
    Depreciation & Amortization
    		 7.01B 6.29B 5.06B 5.19B

    Add to Watchlist